Last updated on September 2017

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Other Details:

For Study Locations, Click Here

Find a site near you

Start Over

Research Center

Located in: Additional Locations, CT USA
  Connect »